Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Financial Flexibility Index
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥28.14 Million (operating CF CN¥22.69 Million minus capex CN¥5.45 Million) represents 0% of total liabilities (CN¥2.09 Billion). Check 600222 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Taloph Pharmaceutical Stock Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Henan Taloph Pharmaceutical Stock Co Ltd (600222) cash conversion ratio.
Annual Financial Flexibility Index for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Henan Taloph Pharmaceutical Stock Co Ltd. Explore Henan Taloph Pharmaceutical Stock Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥68.28 Million | CN¥47.16 Million | CN¥1.98 Billion | ▲ +2831.4% |
| 2024 | 0.00x | CN¥-2.35 Million | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -102.8% |
| 2023 | 0.04x | CN¥86.87 Million | CN¥43.74 Million | CN¥1.95 Billion | ▲ +252.9% |
| 2022 | -0.03x | CN¥-57.78 Million | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -142.1% |
| 2021 | 0.07x | CN¥138.73 Million | CN¥99.66 Million | CN¥2.01 Billion | ▼ -12.0% |
| 2020 | 0.08x | CN¥146.08 Million | CN¥73.43 Million | CN¥1.86 Billion | ▼ -24.8% |
| 2019 | 0.10x | CN¥149.20 Million | CN¥41.53 Million | CN¥1.43 Billion | ▼ -18.8% |
| 2018 | 0.13x | CN¥185.88 Million | CN¥119.47 Million | CN¥1.44 Billion | ▲ +147.8% |
| 2017 | 0.05x | CN¥67.51 Million | CN¥23.17 Million | CN¥1.30 Billion | ▼ -54.1% |
| 2016 | 0.11x | CN¥130.21 Million | CN¥70.60 Million | CN¥1.15 Billion | ▲ +15.9% |
| 2015 | 0.10x | CN¥111.31 Million | CN¥49.27 Million | CN¥1.14 Billion | ▼ -13.8% |
| 2014 | 0.11x | CN¥125.17 Million | CN¥89.54 Million | CN¥1.11 Billion | ▲ +525.0% |
| 2013 | 0.02x | CN¥15.60 Million | CN¥-6.65 Million | CN¥861.22 Million | ▼ -83.8% |
| 2012 | 0.11x | CN¥102.35 Million | CN¥87.45 Million | CN¥912.93 Million | ▲ +44.5% |
| 2011 | 0.08x | CN¥64.52 Million | CN¥105.20K | CN¥831.28 Million | ▲ +634.9% |
| 2010 | 0.01x | CN¥6.78 Million | CN¥-20.00 Million | CN¥641.92 Million | ▼ -89.2% |
| 2009 | 0.10x | CN¥49.70 Million | CN¥21.45 Million | CN¥506.12 Million | ▼ -36.6% |
| 2008 | 0.15x | CN¥59.11 Million | CN¥18.13 Million | CN¥381.43 Million | ▼ -21.4% |
| 2007 | 0.20x | CN¥63.75 Million | CN¥21.34 Million | CN¥323.29 Million | ▲ +66.2% |
| 2006 | 0.12x | CN¥38.23 Million | CN¥1.59 Million | CN¥322.24 Million | ▲ +59.5% |
| 2005 | 0.07x | CN¥20.73 Million | CN¥276.30K | CN¥278.70 Million | ▼ -36.4% |
| 2004 | 0.12x | CN¥33.15 Million | CN¥18.25 Million | CN¥283.44 Million | ▲ +52.1% |
| 2003 | 0.08x | CN¥20.63 Million | CN¥3.74 Million | CN¥268.36 Million | ▲ +47.2% |
| 2002 | 0.05x | CN¥13.82 Million | CN¥7.47 Million | CN¥264.70 Million | ▼ -90.5% |
| 2001 | 0.55x | CN¥113.76 Million | CN¥55.03 Million | CN¥206.07 Million | ▼ -17.7% |
| 2000 | 0.67x | CN¥108.99 Million | CN¥875.36K | CN¥162.45 Million | ▼ -43.4% |
| 1999 | 1.19x | CN¥179.18 Million | CN¥99.32 Million | CN¥151.10 Million | ▲ +596.0% |
| 1998 | 0.17x | CN¥28.08 Million | CN¥28.04 Million | CN¥164.79 Million | — |